Clinical Trials Directory

Trials / Unknown

UnknownNCT03201666

Comparison of Karyotyping, CMA and NIPT for Prenatal Diagnosing Chromosomal Anomalies

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
YiYang Zhu · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This diagnostic test is aimed to compare the Karyotyping, CMA and NIPT for prenatal diagnosing chromosomal anomalies. Pregnant women who needed prenatal genetic diagnosis meted the study criterion; fetal amniotic fluid was regular examined by Karyotyping and CMA, and maternal peripheral blood was collected for NIPT detecting. And the CMA result as a golden standard, the main outcome is compared the diagnostic efficacy of NIPT for diagnosing chromosomal anomalies.

Detailed description

Aim: to compare the Karyotyping, CMA and NIPT for prenatal diagnosing chromosomal anomalies. Design: diagnostic test Set: Prenatal diagnosis center of Taizhou City Study population: The Pregnant women who needed amniocenteses for prenatal genetic diagnosis were recruited. Methods: amniotic fluid was regular examined by Karyotyping and CMA, and maternal peripheral blood was used for collected for NIPT detecting. Statistic: CMA result as a golden standard, the main outcome is compared the diagnostic efficacy of NIPT for diagnosing chromosomal anomalies.

Conditions

Timeline

Start date
2016-07-01
Primary completion
2017-07-01
Completion
2017-12-31
First posted
2017-06-28
Last updated
2017-06-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03201666. Inclusion in this directory is not an endorsement.